Why the study?
Does oral verapamil reduce the frequency of transient ischaemic attacks in patients with unstable angina at rest attributed to coronary vasospasm?
Does oral verapamil reduce the frequency of transient ischaemic attacks in patients with unstable angina at rest attributed to coronary vasospasm?
Oral verapamil significantly reduces the frequency of ischemic attacks in patients with unstable angina at rest caused by coronary vasospasm.
Answers are grounded in this paper and cite their sources.
Verapamil merits consideration in vasospastic unstable angina; confirms calcium antagonism efficacy in this RCT.
A therapeutic trial with verapamil, a calcium-antagonist drug, was performed in 12 patients admitted to our coronary care unit because of frequent daily attacks of angina at rest attributed to coronary vasospasm. After a 48-hour run-in period, oral verapamil 480 mg/day and placebo were administered alternately during 4 randomised 48-hour periods. Transient ischaemic attacks with ST segment elevation or depression, with or without pain, were documented by continuous electrocardiographic monitoring. The number of attacks during the run-in and 2 placebo periods were 128, 123, and 130, respectively, and 31 and 23 during the 2 treatment periods (P less than 0.006 and P less than 0.003). This drug therefore appears to be effective in the management of patients with frequent attacks of angina at rest.
No takes yet. Share an insight, caveat, or question.
Parodi et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: